{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Arcede Pharma AB (publ)", "shortName": "ARCEDE PHARMA AB", "regularMarketPrice": 0.1425, "regularMarketChangePercent": 19.246864, "messageBoardId": "finmb_1786914122", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.44117647, "fiftyTwoWeekLow": 0.1105, "fiftyTwoWeekHigh": 0.255, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.031999998, "fiftyTwoWeekLowChangePercent": 0.28959274, "fiftyTwoWeekRange": "0.1105 - 0.255", "fiftyTwoWeekHighChange": -0.1125, "epsTrailingTwelveMonths": -0.05, "sharesOutstanding": 5846320, "fiftyDayAverage": 0.15587, "fiftyDayAverageChange": -0.013370007, "fiftyDayAverageChangePercent": -0.08577665, "twoHundredDayAverage": 0.1687069, "twoHundredDayAverageChange": -0.026206896, "twoHundredDayAverageChangePercent": -0.1553398, "marketCap": 1450536, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1672815600000, "priceHint": 4, "regularMarketChange": 0.023000002, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.1425, "regularMarketDayRange": "0.1195 - 0.1425", "regularMarketDayLow": 0.1195, "regularMarketVolume": 60, "regularMarketPreviousClose": 0.1195, "bid": 0.1195, "ask": 0.24, "fullExchangeName": "Frankfurt", "regularMarketOpen": 0.1195, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "symbol": "Z61.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Medicon Village", "address2": "Scheeletorget 1", "city": "Lund", "zip": "22381", "country": "Sweden", "phone": "46 7 23 12 27 44", "website": "https://arcedepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Arcede Pharma AB (publ) develops drug candidates to treat chronic obstructive pulmonary disease (COPD) and asthma. Its project portfolio includes RCD405 for the treatment of COPD and asthma. The company was incorporated in 2003 and is based in Lund, Sweden.", "companyOfficers": [], "maxAge": 86400}}], "error": null}}